SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10091802
Source:
http://linkedlifedata.com/resource/pubmed/id/10091802
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001675
,
umls-concept:C0006118
,
umls-concept:C0087111
,
umls-concept:C0146224
,
umls-concept:C0205099
,
umls-concept:C0205225
,
umls-concept:C0555198
,
umls-concept:C1446468
pubmed:issue
5
pubmed:dateCreated
1999-4-7
pubmed:abstractText
Topotecan activity was evaluated for the treatment of malignant glioma.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA 57725
,
http://linkedlifedata.com/resource/pubmed/grant/NS 20023
,
http://linkedlifedata.com/resource/pubmed/grant/NS 30245
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Topotecan
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0008-543X
pubmed:author
pubmed-author:ArbuckSS
,
pubmed-author:CokgorII
,
pubmed-author:FieldsSS
,
pubmed-author:FriedmanA HAH
,
pubmed-author:FriedmanH SHS
,
pubmed-author:GradelFF
,
pubmed-author:HoughtonP JPJ
,
pubmed-author:KerbyTT
,
pubmed-author:McLendonR ERE
,
pubmed-author:ZilischJ EJE
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1160-5
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10091802-Adult
,
pubmed-meshheading:10091802-Aged
,
pubmed-meshheading:10091802-Antineoplastic Agents
,
pubmed-meshheading:10091802-Brain Neoplasms
,
pubmed-meshheading:10091802-Disease-Free Survival
,
pubmed-meshheading:10091802-Drug Administration Schedule
,
pubmed-meshheading:10091802-Female
,
pubmed-meshheading:10091802-Glioma
,
pubmed-meshheading:10091802-Humans
,
pubmed-meshheading:10091802-Magnetic Resonance Imaging
,
pubmed-meshheading:10091802-Male
,
pubmed-meshheading:10091802-Middle Aged
,
pubmed-meshheading:10091802-Neoplasm, Residual
,
pubmed-meshheading:10091802-Neoplasm Recurrence, Local
,
pubmed-meshheading:10091802-Topotecan
,
pubmed-meshheading:10091802-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.
pubmed:affiliation
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II